JPM down grades stock to neutral and lowers target to 14 after "expensive acquisition of Danvers and their declining excess capital". Based on stock reaction and the coming onslaught of downgrades myself and other current shareholders have a tough decision to make. Cut and run or have our capital sit on the side lines for half the year. A dividend boost could have helped. The annual meeting will hopefully lead to some changes.